Moisturizing, repairing and tightening composition and application thereof in cosmetics
Through the combination of sodium hyaluronate disaccharide, quinoa bran extract, artemisia tangerine extract and huanghuaqianhu extract, the synthesis of collagen and pyroprotein is promoted, and the existing cosmetics' action pathways are solved. This results in poor results, achieving effective skin moisturizing and repair and wrinkle improvement.
Patent Information
- Application Number
- CN202411007909.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-07-25
AI Technical Summary
The existing cosmetics with moisturizing, repairing and firming effects have relatively single ways of effect, and the firming effect is poor, which cannot effectively improve the problem of dryness, redness, sagging and wrinkles of the skin.
The hyaluronate disaccharide, quinoa bran extract and artemisia tangerine extract are combined with the huanghuaqianhu extract to form a moisturizing and repairing and firming composition, and promote the synthesis of type IV and type XVII collagen, The expression of sapase-14 activity improves skin structure.
Significantly improves skin sagging and wrinkles, improves skin elasticity and moisturizing ability, has good skin care effects and reduces costs.
Smart Images

Figure BDA0004963483270000072 
Figure BDA0004963483270000081 
Figure BDA0004963483270000082
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of cosmetics, and particularly relates to a moisturizing, repairing and firming composition and application thereof in cosmetics. Background Art
[0002] The information disclosed in the background of the invention is only intended to enhance the understanding of the overall background of the invention and should not be necessarily regarded as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] Skin, the largest organ in the human body, consists of the epidermis, dermis, and subdermal tissue. It is a multilayered, highly nonlinear, anisotropic viscoelastic material, each with its own composition and mechanical properties. There is also a layer called the dermal-epidermal junction (DEJ) between the dermis and the epidermis. It is a dense collagen network that forms an undulating dermal-epidermal junction structure, which provides good structural support for the epidermis and dermis. The DEJ controls the structural integrity of the skin and plays multiple roles in skin homeostasis and function. Epidermal cells continue to move upward, forming the stratum corneum in the epidermis and finally fall off. The DEJ can enhance the adhesion and physical interlocking of the epidermal layer, create niches for epidermal stem cells, and regulate the cell microenvironment; in addition, it acts as a physical boundary layer between fibroblasts and keratinocytes, providing an exchange barrier for dynamic equilibrium signal transduction. The DEJ is also responsible for the exchange of nutrients from the epidermis to the dermis. As a complex signaling platform, the DEJ controls dermal-epidermal signaling and plays an important role in maintaining a healthy epidermis and dermis. Without the DEJ to maintain the relationship between the epidermis and dermis, it would be impossible to achieve healthy signal communication from top to bottom.
[0004] Studies have found that the use of some active ingredients that can promote the core composition of DEJ, such as type XVII collagen, type IV collagen, VII collagen and laminin 332, in daily chemical products can have a good effect on maintaining the structure and homeostasis of DEJ. Type IV collagen present in DEJ is the most abundant collagen fiber in the dense layer and is also the main component. Type IV collagen is produced by keratinocytes and fibroblasts and is the main component of anchoring fibrils, providing mechanical support for keratinocytes. Type XVII collagen is another structural component of anchoring filaments. It plays an important role in the assembly and function of cell-matrix adhesion structures, and plays an important role in transmembrane signal transduction and keratinocyte differentiation. Genetic defects in type XVII collagen can lead to skin atrophy and a decrease in the number of epidermal stem cells. DEJ is a good target for skin care products. Ingredients that enhance DEJ repair can improve epidermal dermal communication and skin homeostasis, thereby strengthening defense against skin aging.
[0005] The skin barrier plays an important role in preventing transepidermal water loss (TEWL), penetration of external immunogens and microorganisms. The stratum corneum, as the outermost layer of the skin barrier, is composed of keratinocytes embedded in intercellular lipids. The natural moisturizing factor (NMF) synthesized in keratinocytes is a key component of the skin's stratum corneum moisturizing. It is completely degraded into free amino acids by filaggrin (FLG) under the hydrolysis of caspase-14, and finally forms a natural moisturizing factor to maintain the relative humidity of the skin. Each keratinocyte is surrounded by a protein shell called the corneocyte envelope (CE), which is composed of loricrin (LOR). The content of LOR directly affects the strength of the skin barrier.
[0006] However, the inventors have found that the cosmetics currently on the market that have moisturizing, repairing and firming effects have a relatively single action pathway or poor firming effects. Therefore, it is necessary to develop a cosmetic that can effectively firm the skin, moisturize and repair the skin to improve skin dryness, redness, sagging and wrinkles. Summary of the invention
[0007] In view of the deficiencies of the prior art, the present invention provides a moisturizing, repairing and firming composition and its application in cosmetics. Specifically, the present invention prepares a composition by compounding sodium hyaluronate disaccharide, a quinoa bran extract and an Artemisia capillaris extract, and a Peucedanum peucedanum extract; and then uses the composition as the main active ingredient to prepare a skin care cosmetic. It has been verified by experiments that it has a good effect of improving skin sagging and wrinkles, and can be used in cosmetics to improve skin wrinkles and sagging problems, so it has good application prospects in the field of cosmetics.
[0008] In order to achieve the above technical objectives, the technical solution provided by the present invention is as follows:
[0009] The first aspect of the present invention provides a moisturizing, repairing and firming composition, which comprises the following components in parts by weight:
[0010] 0.01-1.0 parts of sodium hyaluronate disaccharide, 1.0-15.0 parts of a combination of quinoa bran extract and Artemisia capillaris extract, and 1.0-15.0 parts of Peucedanum pekinensis extract;
[0011] Furthermore, the moisturizing, repairing and firming composition comprises the following components in parts by weight:
[0012] 0.1-0.6 parts of sodium hyaluronate disaccharide, 5.0-10.0 parts of a combination of quinoa bran extract and Artemisia capillaris extract, and 5.0-10.0 parts of Peucedanum peucedanum extract.
[0013] Wherein, the sodium hyaluronate disaccharide can be obtained in a commercial manner.
[0014] The preparation method of the Peucedanum peucedanum extract is as follows:
[0015] S1, Peucedanum peucedanum was crushed and sieved, then immersed in ethanol for ultrasonic extraction, filtered, the filtrate was collected, the residue was repeatedly extracted 2-3 times, and the obtained filtrate was combined;
[0016] S2, concentrating the filtrate obtained in step S1 under reduced pressure, recovering ethanol until there is no alcohol taste, adding butanediol thereto, stirring evenly, and filtering to obtain the product;
[0017] In the step S1, a 30-60 mesh sieve is used for the sieving process;
[0018] The ethanol is selected from 60% to 85% ethanol, the solid-liquid ratio is 1:8-1:10 (g / mL), and the soaking time is controlled to be 20-40min; the ultrasonic power during the ultrasonic extraction process is 100-300W, and the ultrasonic treatment time is 40-60min;
[0019] In step S2, the reduced pressure concentration is specifically: performing reduced pressure distillation at 50-60° C. to recover ethanol until there is no alcohol taste to obtain Peucedanum peucedanum concentrated solution, adding 2-2.5 times the mass of butanediol of the Peucedanum peucedanum concentrated solution, stirring evenly, and filtering to obtain the solution.
[0020] The quinoa bran extract and Artemisia capillaris extract composition can be prepared by any of the following preparation methods:
[0021] Specifically, extraction method 1: (the present invention, the quinoa bran extract and Artemisia capillaris extract composition obtained by this method is referred to as KNYC① composition), the specific method is as follows:
[0022] S1, crude extraction: dry and crush the Artemisia capillaris, sieve it, add water and perform ultrasonic atomization extraction to obtain a crude extract of Artemisia capillaris;
[0023] S2, deacidification: filtering the crude extract of Artemisia capillaris obtained in step S1, adding neutral alumina thereto, stirring and filtering out solids, and obtaining an extract of Artemisia capillaris;
[0024] S3, adsorption: using macroporous resin to adsorb the Artemisia capillaris extract;
[0025] S4, preparation of eluent: mixing quinoa bran with butanediol, extracting at low temperature by microwave heating, filtering out solid matter, and diluting the filtrate with water to obtain an eluent;
[0026] S5, eluting: using the eluate obtained in step S4 to elute the macroporous resin adsorbed with the Artemisia capillaris extract obtained in step S3, to obtain a refined extract;
[0027] S6, purification: The refined extract obtained in step S5 is filtered and purified to obtain the KNYC① composite material.
[0028] Among them, in the step S1, the particle size of the dried, crushed and sieved Artemisia capillaris is between 50 mesh and 120 mesh, the mass ratio of the sieved Artemisia capillaris particles to water is 1:6-10 (preferably 1:8), the ultrasonic atomization extraction temperature is controlled at 25-40°C, and the extraction time is 30-35min.
[0029] In the step S2, the mesh size of the neutral alumina is 80 to 150 meshes, preferably 100 meshes.
[0030] In step S3, the macroporous resin is any one or more of D101, AB-8, and HPD-100, preferably AB-8;
[0031] Furthermore, the macroporous resin is placed in a separation column, and the separation column can be a single column or multiple separation columns connected in series.
[0032] In step S4, the microwave heating extraction temperature is 45-55° C., and the extraction time is 90-100 min.
[0033] At the same time, the quinoa bran extract and Artemisia capillaris extract composition can also be obtained by a one-step direct mixed extraction method, i.e., extraction method 2 (the quinoa bran extract and Artemisia capillaris extract composition obtained by this method is referred to as KNYC② composition in the present invention), and the specific method is as follows:
[0034] S1. Dry and grind quinoa bran and Artemisia capillaris, immerse them in an ethanol solution for ultrasonic-microwave synergistic extraction, centrifuge the extract, take the supernatant and filter it under reduced pressure, collect the filtrate, repeat the extraction of the filter residue 2 to 3 times, and combine the obtained filtrates;
[0035] S2, the filtrate obtained in step S1 is concentrated under reduced pressure, glycerol is added after concentration, the mixture is stirred evenly, and filtered to obtain the product.
[0036] Wherein, in the step S1, the quinoa bran powder is sieved with a 30-60 mesh sieve, and the Artemisia capillaris powder is sieved with a 40-100 mesh sieve; the feeding ratio (mass ratio) of quinoa bran and Artemisia capillaris powder is 1:0.9-1:1.1;
[0037] The ethanol solution is selected from 50% to 80% ethanol solution, the solid-liquid ratio is 1:45 to 1:60 (g / mL), the ultrasonic-microwave synergistic extraction, the ultrasonic power is 100 to 200W, the microwave power is 400 to 500W, the processing temperature is 25°C to 45°C, and the processing time is 1min to 3min;
[0038] In the step S2, the reduced pressure concentration is specifically carried out under reduced pressure distillation at 50-60° C., concentrated to 4-6 times the mass of quinoa bran and Artemisia capillaris powder, and glycerin of the same mass as the concentrated solution is added and stirred evenly.
[0039] The present invention has verified through experiments that the above composition can improve skin dryness, redness, sagging, and wrinkles by promoting the synthesis of type IV and type XVII collagen, promoting the expression of loricrin (LOR), and promoting the expression of Caspase-14, while being safe and non-toxic. Therefore, the second aspect of the present invention provides the use of the above moisturizing, repairing, and firming composition in the preparation of cosmetics. Obviously, the cosmetic has the effects of improving skin dryness, redness, sagging, and wrinkles. The cosmetic can be a skin care product.
[0040] The third aspect of the present invention provides a cosmetic for improving dryness, redness, sagging and wrinkles of the skin, wherein the cosmetic comprises at least the above-mentioned moisturizing, repairing and firming composition. The cosmetic may be a skin care product.
[0041] According to the cosmetics of the present invention, the amount of the oil-controlling, soothing, skin care, moisturizing, repairing and firming composition added is 0.5-15%, preferably 2-8%, such as 1%, 3%, 5%, 7%, 10%, 12%, 14% or 15%, based on the total mass of the cosmetics.
[0042] The cosmetics may also contain any other raw material ingredients permitted to be added in the cosmetics field, including but not limited to emulsifiers, emollients, moisturizers, thickeners, preservatives, and the like.
[0043] At the same time, the present invention can also prepare different cosmetic dosage forms, such as essence water, essence lotion, essence cream, etc., by reasonably adding the above-mentioned raw material ingredients. At the same time, based on the above-mentioned basic cosmetic categories, other cosmetic categories are further derived and prepared, which obviously belong to the protection scope of this application.
[0044] The fourth aspect of the present invention provides a method for preparing the above-mentioned cosmetics, the method comprising: mixing the moisturizing, repairing and firming composition with other raw material components, without specific limitation herein.
[0045] Beneficial technical effects of one or more of the above technical solutions:
[0046] (1) The moisturizing, repairing and firming composition obtained by the above technical solution can significantly promote the synthesis of type IV and type XVII collagen, promote the synthesis of loricrin (LOR) and Caspase-14, thereby achieving an effective moisturizing, repairing and firming effect;
[0047] (2) The cost of sodium hyaluronate disaccharide is relatively high. The present invention uses a compound of sodium hyaluronate disaccharide, KNYC① and Peucedanum peucedanum extract. When achieving a similar or more significant improvement in promoting type IV and type XVII collagen, the amount of sodium hyaluronate disaccharide used is lower, which greatly saves costs.
[0048] (3) It has been verified through experiments that the KNYC① composition has better skin care effects than the KNYC② composition, thereby making the product more effective and more cost-effective.
[0049] (4) The preparation method of the moisturizing, repairing and firming composition skin care cosmetics obtained by the above technical solution is simple and easy, saves costs, and has good effects on improving skin sagging and wrinkles through human efficacy experiments, so it has good practical application value. DETAILED DESCRIPTION
[0050] It should be noted that the following detailed descriptions are all illustrative and intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0051] It should be noted that the terms used herein are only for describing specific embodiments and are not intended to limit exemplary embodiments according to the present invention. As used herein, unless the context clearly indicates otherwise, the singular form is also intended to include the plural form. In addition, it should be understood that when the terms "comprising" and / or "including" are used in this specification, it indicates the presence of features, steps, operations, devices, components and / or combinations thereof.
[0052] The present invention is further described in conjunction with specific examples. The following examples are only for explaining the present invention and are not intended to limit the content thereof. If the specific experimental conditions are not specified in the examples, they are usually carried out according to conventional conditions or the conditions recommended by the reagent company; the reagents and consumables used in the following examples, unless otherwise specified, can all be obtained from commercial sources.
[0053] The present invention is further explained by the following examples, but it does not constitute a limitation of the present invention. It should be understood that these examples are only used to illustrate the present invention and are not used to limit the scope of the present invention. The test methods for which specific conditions are not specified in the following examples are usually carried out under conventional conditions. It should be noted that the sodium hyaluronate disaccharide in the examples and comparative examples of the present invention was purchased from Shandong Baifu Furuida Pharmaceutical Co., Ltd., trade name: Huanling 400, INCI name: hydrolyzed sodium hyaluronate.
[0054] The KNYC① composition in the examples and comparative examples of the present invention is obtained by the following method:
[0055] S1, crude extraction. After the Artemisia capillaris was dried and crushed, it was sieved twice with a 50-mesh sieve and a 120-mesh sieve. 10.0 kg of fine powder with a particle size between 50 and 120 mesh was weighed, and 80.0 kg of water was used as the extracting liquid for atomization extraction. The extraction temperature was 35°C, the extraction time was 30 min, and the residue was filtered out to obtain the Artemisia capillaris crude extract;
[0056] S2, deacidification. Filter the crude extract of Artemisia capillaris, then add 0.5 kg of 100-mesh neutral alumina, stir for more than 60 minutes, filter out the solid matter, and obtain the extract of Artemisia capillaris;
[0057] S3, adsorption. Use two-stage series separation columns, the resin filling height of each separation column is not less than 500mm, use AB-8 macroporous adsorption resin with a particle size of 0.4-1.0mm, and the total weight of the resin filling of the two-stage separation columns is 15kg; the Artemisia capillaris extract is injected from the top of the first-stage separation column, flows through the first-stage separation column to the top of the second-stage separation column, and flows out from the bottom of the second-stage separation column. Control the liquid inlet flow rate so that the adsorption time (from the initial liquid inlet to the complete liquid outlet) is 30-35min;
[0058] S4, preparation of eluent. Take 16.0 kg of quinoa bran with a particle size less than 100 mesh, add 80.0 kg of butanediol, mix thoroughly, use microwave heating, control the extraction temperature at 50°C, extract for 95 min, filter and obtain quinoa bran extract weighing 86.2 kg. Add 38.8 kg of water to make the total weight of the eluent reach 125.0 kg;
[0059] S5, elution. The eluate obtained in step S4 is injected from the top of the first-stage separation column obtained in step S3, and flows out from the bottom of the second-stage separation column for elution. The total elution time is not less than 30 minutes to obtain a refined extract;
[0060] S6, purification. The refined extract obtained in step S5 is filtered using a 0.22 micron polypropylene membrane, and the filtrate is weighed to be 114.0 kg. The obtained product is the KNYC① composition. The total phenylpropanoid concentration of the product is measured by ultraviolet-visible spectrophotometry (UV) method to be 0.535% W / W, and the total phenylpropanoid content in the product is calculated to be 609.9 g.
[0061] The KNYC② compositions in the examples and comparative examples of the present invention were prepared by the following method:
[0062] S1. Dry Artemisia capillaris to a constant temperature, crush it and sieve it twice with a 40-mesh sieve and a 100-mesh sieve to obtain fine powder with a particle size between 40 mesh and 100 mesh; dry quinoa bran to a constant temperature, crush it and pass it through a 60-mesh sieve, immerse the sieved quinoa bran powder and Artemisia capillaris powder in an 80% ethanol solution in a mass ratio of 1:1, and perform ultrasonic-microwave synergistic extraction, centrifuge the extract, take the supernatant and filter it under reduced pressure, collect the filtrate, extract the residue repeatedly twice, and combine the obtained filtrate; wherein, the solid-liquid ratio of quinoa bran powder and Artemisia capillaris powder to ethanol solution is 1:50 g / mL; during the ultrasonic-microwave synergistic extraction process: the ultrasonic power is 150 W, the microwave power is 400 W, the processing temperature is 35 ° C, and the processing time is 2 min;
[0063] S2. The filtrate obtained in step S1 is concentrated under reduced pressure at 50° C. to 5 times the mass of quinoa bran and Artemisia capillaris powder, and glycerin having the same mass as the concentrate is added, stirred evenly, and filtered to obtain the product.
[0064] In the examples and comparative examples of the present invention, the Peucedanum peucedanum extract is prepared by the following method:
[0065] S1. Crush the Peucedanum peucedanum powder, pass it through a 50-mesh sieve, and soak it in 80% ethanol for 30 minutes, then perform ultrasonic extraction, filter, collect the filtrate, repeat the extraction twice with the residue, and combine the obtained filtrate; wherein, the solid-liquid ratio of Peucedanum peucedanum powder to ethanol is 1:10 g / mL, the ultrasonic power during ultrasonic extraction is 200 W, and the ultrasonic treatment time is 50 minutes.
[0066] S2. The filtrate obtained in step S1 is concentrated by vacuum distillation at 50° C., and the ethanol is recovered until there is no alcohol smell to obtain Peucedanum peucedanum concentrated solution. Butanediol with a mass of 2 times of the Peucedanum peucedanum concentrated solution is added, and the mixture is stirred evenly and filtered to obtain the concentrate.
[0067] Examples 1-3 and Comparative Examples 1-8:
[0068] The specific scheme is shown in Table 1 below, calculated by mass fraction. The preparation method is as follows: Sodium hyaluronate disaccharide, KNYC① composition, KNYC② composition and Peucedanum peucedanum extract are mixed together and dissolved in purified water.
[0069] Table 1 Specific examples and comparative examples ingredient list
[0070]
[0071]
[0072] Example 4: Moisturizing, repairing and firming essence lotion
[0073] The above composition is used to prepare an essence milk product containing the moisturizing, repairing and firming composition, and the formula is shown in Table 2.
[0074] Table 2 Essence milk product formula
[0075]
[0076] Preparation method of essence milk:
[0077] S1: Preparation of aqueous phase: Add the raw materials in phase A respectively, heat to 80-85°C and stir to dissolve;
[0078] S2: Preparation of oil phase: Add the raw materials in phase B respectively and heat to 75-80°C to melt;
[0079] S3: Combine phase A and phase B, start homogenization (3000 rpm), homogenize for 12 min, and start cooling;
[0080] S4: When the temperature drops to 65-70°C, add phase C, stir to dissolve, and continue to cool after dissolution;
[0081] S5: When the temperature drops to 40-45°C, add the D phase ingredients, stir to dissolve and disperse evenly, and the essence milk product is obtained.
[0082] Test Example 1: Stability Test Experiment
[0083] The samples of Examples 1 to 3 and Comparative Examples 1 to 8 were placed at room temperature, -18°C, 4°C, 45°C, and subjected to a cold and hot cycle (-18°C, 4°C, 45°C, cycled once every 3 days) for the corresponding period of time for stability observation, and the stability of the product was judged by whether precipitation occurred. If no precipitation instability occurred, the stability passed. The specific results are shown in Table 3 below.
[0084] Table 3 Stability test results
[0085]
[0086] Note: √ means the stability has passed and there is no precipitation; × means there is slight precipitation; ×× means there is severe precipitation; ○ means the color of the solution has changed and the color has become slightly darker; ○ means the color of the solution has changed and the color has become seriously darker.
[0087] As can be seen from Table 3, KNYC① composition and KNYC② composition are not stable when they exist alone. However, KNYC① composition can pass the stability test when it exists with disodium hyaluronate and Peucedanum peucedanum extract. However, KNYC② composition cannot pass the stability test when it is mixed with disodium hyaluronate and Peucedanum peucedanum extract.
[0088] Test Example 2: Experiment on promoting the expression of Collagen Ⅳ and Collagen ⅩⅦ genes
[0089] The experiment used human skin fibroblasts (HSF) as a model cell line. The cells were inoculated into 6-well plates and incubated overnight in a 37°C, 5% CO2 incubator. Each plate was set up with a blank control group (BC), a positive control group (PC) and a sample group. When the cell plating rate in the 6-well plate reached 40% to 60%, the drugs were divided into groups and administered, with 3 replicates in each group. 2 mL of culture medium was added to each well of the BC group, and 2 mL of culture medium containing TGF-β1 (DMEM, Gibco) was added to each well of the PC group. The test substance, i.e., the sample group working solution, was prepared according to the test scheme (Table 4). After the administration was completed, the 6-well plate was placed in a CO2 incubator and cultured for 24 h. The old solution was discarded, washed twice with PBS, and 1 mL of RNAiso Plus (Aikerui Biotechnology Co., Ltd.) was added to each well. After blowing and lysing the cells, the samples were collected to extract RNA. After reverse transcription to cDNA, fluorescent quantitative PCR was performed, using 2- △△CT Method to calculate the results.
[0090]
[0091] GraphPad Prism was used for graphing, and the results were expressed as Mean ± SD. The t-test was used for statistical analysis among the groups. All statistical analyses were two-tailed. 0.01<P<0.05 was considered to be significantly different, and P<0.01 was considered to be extremely significantly different. The mRNA amplification factor of the BC group was normalized, and compared with the BC group, the significance was indicated by *, P-value<0.05 was indicated by *, and P-value<0.01 was indicated by **.
[0092] Table 4 Test plan
[0093]
[0094] Note: Sample concentration is 1 mg / mL (diluted with deionized water).
[0095] Table 5 Summary of Collagen Ⅳ gene content detection results
[0096]
[0097]
[0098] (Note: ## indicates p<0.01 compared with blank control; ** indicates p<0.01 compared with blank control; * indicates p<0.01 compared with blank control <p<0.05。)
[0099] It can be seen from Table 5 that compared with the BC group, the Collagen IV gene content in the PC group increased significantly, indicating that the positive control test was effective. Single sodium hyaluronate disaccharide components and Peucedanum peucedanum extract do not have the function of promoting the expression of Collagen IV genes. Comparative Example 9 contains both sodium hyaluronate disaccharide and Peucedanum peucedanum extract, and the up-regulation rate of Collagen IV gene is 10.0%, and the two have a certain synergistic effect. Examples 1 to 3 all contain sodium hyaluronate disaccharide and Peucedanum peucedanum extract KNYC① composition, with up-regulation rates of 54.0%, 156.0% and 121.0%, and the three have significant synergistic promotion effects. It can also be seen that the efficacy of the KNYC① composition is stronger than that of the KNYC② composition, and the synergistic promotion effect with the other two is also higher than that of the KNYC② composition.
[0100] Table 6 Summary of Collagen ⅩⅦ gene content detection results
[0101]
[0102]
[0103] (Note: ## indicates p<0.01 compared with blank control; ** indicates p<0.01 compared with blank control; * indicates p<0.01 compared with blank control <p<0.05。)
[0104] It can be seen from Table 6 that compared with the BC group, the CollagenⅩⅦ gene content in the PC group increased significantly, indicating that the positive control test was effective. Compared with the BC group, the single KNYC① composition does not have the ability to promote the expression of the CollagenⅩⅦ gene. Examples 1 to 3 and Comparative Examples 1, 4, 5, 6, 7, and 8 all have a certain ability to promote the expression of the CollagenⅩⅦ gene. At the same time, it can also be shown that this composition has the function of synergistically promoting the expression of the CollagenⅩⅦ gene. At the same time, it can also be seen that the efficacy of the KNYC① composition is stronger than that of the KNYC② composition, and the synergistic promotion effect with the other two is also higher than that of the KNYC② composition.
[0105] Experimental Example 3: Experiment on promoting the expression of Caspase-14 and LOR genes
[0106] After keratinocytes were revived, when the plating rate reached about 60%, the cells were inoculated into 6-well plates and incubated overnight in a 37°C, 5% CO2 incubator. According to the inoculation of cells into 24-well plates, when the cell plating rate in the 24-well plates reached 40% to 60%, the drugs were administered in groups, with 3 replicates per group. A blank control group (BC), a positive control group (PC) and a sample group were set up on each plate, and the sample groups were configured according to Table 7. 2 mL of culture medium was added to each well of the blank control group, 2 mL of culture medium containing WY14643 (Sigma) was added to each well of the PC group (KcGrowth, Guangdong Boxi Biology), and 2 mL of culture medium containing the corresponding concentration of the sample to be tested was added to each well of the sample group. After the administration was completed, the 6-well plate was placed in a CO2 incubator (37°C, 5% CO2) and cultured for 24 hours. After the incubation, the old solution was discarded, and the cells were washed twice with PBS. 1 mL of RNAiso Plus (Aikerui Biotechnology Co., Ltd.) was added to each well. After blowing and lysing the cells, samples were collected for RNA extraction, reverse transcription to cDNA, and fluorescence quantitative PCR detection was performed. Method to calculate the results.
[0107]
[0108] GraphPad Prism was used for graphing, and the results were expressed as Mean ± SD. The t-test was used for statistical analysis among the groups. All statistical analyses were two-tailed. 0.01<P<0.05 was considered to be significantly different, and P<0.01 was considered to be extremely significantly different. The mRNA amplification factor of the BC group was normalized, and compared with the BC group, the significance was indicated by *, P-value<0.05 was indicated by *, and P-value<0.01 was indicated by **.
[0109] Table 7 Test plan
[0110]
[0111] Note: Sample concentration is 1 mg / mL (diluted with deionized water).
[0112] Table 8 Summary of Caspase-14 gene content detection results
[0113]
[0114]
[0115] (Note: ## indicates p<0.01 compared with blank control; ** indicates p<0.01 compared with blank control; * indicates p<0.01 compared with blank control <p<0.05。)
[0116] It can be seen from Table 8 that compared with the BC group, the Caspase-14 gene content in the PC group increased significantly, indicating that the positive control test was effective. Compared with the BC group, the single Peucedanum peucedanum extract did not have the effect of promoting the expression of the Caspase-14 gene. At the same time, Examples 1 to 3 and Comparative Examples 1, 2, 3, 5, 6, 7, and 8 all had a certain effect of promoting the expression of the Caspase-14 gene. At the same time, it can also be shown that this composition has the function of synergistically promoting the expression of the Caspase-14 gene. At the same time, it can also be seen that the efficacy of the KNYC① composition is stronger than that of the KNYC② composition, and the synergistic promotion effect with the other two is also higher than that of the KNYC② composition.
[0117] Table 9 Summary of LOR gene content detection results
[0118]
[0119]
[0120] (Note: ## indicates p<0.01 compared with blank control; ** indicates p<0.01 compared with blank control; * indicates p<0.01 compared with blank control <p<0.05。)
[0121] It can be seen from Table 9 that compared with the BC group, the LOR gene content in the PC group increased significantly, indicating that the positive control test was effective. Compared with the BC group, the single Peucedanum peucedanum extract did not have the effect of promoting LOR gene expression. At the same time, Examples 1 to 3 and Comparative Examples 1, 2, 3, 5, 6, 7, and 8 all have a certain effect of promoting LOR gene expression. At the same time, it can also be shown that this composition has the function of synergistically promoting LOR gene expression. At the same time, it can also be seen that the efficacy of the KNYC① composition is stronger than that of the KNYC② composition, and the synergistic promotion effect with the other two is also higher than that of the KNYC② composition.
[0122] Test Example 4: Evaluation of moisturizing, firming and repairing effects on human body
[0123] Example 4 was tested for its moisturizing, firming and repairing effects on human skin. A total of 36 subjects, aged 30 to 55 years old, completed the test and met the voluntary inclusion and exclusion criteria.
[0124] Directions for use: Cleanse your face in the morning and evening and use an appropriate amount of the emulsion in Example 4, apply evenly on the face, and massage gently until absorbed. Use twice a day, once in the morning and once in the evening, for 28 consecutive days.
[0125] Detection time: before using the sample (D0), 14 days after using the sample (D14), and 28 days after using the sample (D28).
[0126] Test method:
[0127] 1. The facial image analyzer VISIA-CR is used to compare the areas of quantitative index wrinkles (forehead wrinkles, crow's feet, under-eye wrinkles, glabellar wrinkles, nasolabial folds, and marionette lines) as a parameter for evaluating the improvement of facial wrinkles.
[0128] 2. Skin elasticity tester MPA580 is used to detect skin elasticity and firmness.
[0129] 3. The skin moisture content tester Corneometer is used to detect the relative moisture content of the skin surface.
[0130] 4. Skin water loss tester Aqua Flux is used to detect the transepidermal water loss (TWEL) value of the skin and evaluate the skin barrier function.
[0131] Experimental parameters:
[0132] 1. Skin elasticity: The larger the skin elasticity R2, R5, R7 and Q1 values are, the better the skin elasticity is. F4 is used to evaluate skin firmness. The smaller the F4 value is, the firmer the skin is.
[0133] 2. Skin moisture content: The larger the skin moisture content value, the higher the skin moisture content.
[0134] 3. Transepidermal water loss (TWEL) value: The lower the TWEL value, the better the skin barrier.
[0135] Calculation formula:
[0136] SPSS Statistics 25 was used for statistical analysis, with two-tailed test and test level α = 0.05.
[0137] The measurement data were analyzed by the normal distribution test results and the difference analysis method was selected: if the measured values were normally distributed, the t-test method was used for statistical analysis; if they were non-normally distributed, the rank sum test method was used for statistical analysis.
[0138] The test results are shown in Tables 10 to 18.
[0139] Table 10 Descriptive statistics of wrinkle grade assessment (n=36)
[0140]
[0141]
[0142] Table 11 Statistical analysis results of wrinkle grade assessment (n=36)
[0143]
[0144] Statistical analysis results: “-”: no statistically significant difference (P≥0.05); “*”: statistically significant difference (0.01≤P<0.05); “**”: statistically significant difference (0.001≤P<0.01); “***”: statistically significant difference (P<0.001).
[0145] Table 12 Skin elasticity R2 descriptive statistics (n = 36)
[0146]
[0147] Statistical analysis results: “-”: no statistically significant difference (P≥0.05); “*”: statistically significant difference (0.01≤P<0.05); “**”: statistically significant difference (0.001≤P<0.01); “***”: statistically significant difference (P<0.001).
[0148] Table 13 Descriptive statistics of skin elasticity R5 content (n=36)
[0149]
[0150] Statistical analysis results: “-”: no statistically significant difference (P≥0.05); “*”: statistically significant difference (0.01≤P<0.05); “**”: statistically significant difference (0.001≤P<0.01); “***”: statistically significant difference (P<0.001).
[0151] Table 14 Descriptive statistics of skin elasticity R7 (n=36)
[0152]
[0153] Statistical analysis results: “-”: no statistically significant difference (P≥0.05); “*”: statistically significant difference (0.01≤P<0.05); “**”: statistically significant difference (0.001≤P<0.01); “***”: statistically significant difference (P<0.001).
[0154] Table 15 Descriptive statistics of skin elasticity Q1 (n=36)
[0155]
[0156] Statistical analysis results: “-”: no statistically significant difference (P≥0.05); “*”: statistically significant difference (0.01≤P<0.05); “**”: statistically significant difference (0.001≤P<0.01); “***”: statistically significant difference (P<0.001).
[0157] Table 16 Descriptive statistics of skin firmness F4 (n=36)
[0158]
[0159] Statistical analysis results: “-”: no statistically significant difference (P≥0.05); “*”: statistically significant difference (0.01≤P<0.05); “**”: statistically significant difference (0.001≤P<0.01); “***”: statistically significant difference (P<0.001).
[0160] Table 17 Descriptive statistics of skin moisture content (n=36)
[0161]
[0162] Statistical analysis results: “-”: no statistically significant difference (P≥0.05); “*”: statistically significant difference (0.01≤P<0.05); “**”: statistically significant difference (0.001≤P<0.01); “***”: statistically significant difference (P<0.001).
[0163] Table 18 Descriptive statistics of transepidermal water loss TEWL values (n=36)
[0164]
[0165] Statistical analysis results: “-”: no statistically significant difference (P≥0.05); “*”: statistically significant difference (0.01≤P<0.05); “**”: statistically significant difference (0.001≤P<0.01); “***”: statistically significant difference (P<0.001).
[0166] It can be seen from Tables 10 to 18 that in the 4-week test period, Example 4 has the effect of significantly improving facial wrinkles and significantly improving the firming effect of skin elasticity R2, R5, R7 and Q1, the skin transepidermal water loss TEWL is significantly reduced, and the skin water content is significantly increased. Therefore, the essence lotion containing the moisturizing, repairing and firming composition has good effects on improving facial wrinkles, sagging, moisturizing and repairing.
[0167] The above embodiments are only for illustrating the technical concept and features of the present invention, and their purpose is to enable people familiar with the technology to understand the content of the present invention and implement it accordingly, and they cannot be used to limit the protection scope of the present invention. Any equivalent changes or modifications made according to the spirit of the present invention should be included in the protection scope of the present invention.
Claims
1. A moisturizing, repairing and firming composition, characterized in that: The moisturizing, repairing and firming composition comprises the following components in parts by weight: 0.01-1.0 parts of sodium hyaluronate disaccharide, 1.0-15.0 parts of a combination of quinoa bran extract and Artemisia capillaris extract, and 1.0-15.0 parts of Peucedanum peucedanum extract.
2. The moisturizing, repairing and firming composition according to claim 1, characterized in that: The moisturizing, repairing and firming composition comprises the following components in parts by weight: 0.1-0.6 parts of sodium hyaluronate disaccharide, 5.0-10.0 parts of a combination of quinoa bran extract and Artemisia capillaris extract, and 5.0-10.0 parts of Peucedanum peucedanum extract.
3. The moisturizing, repairing and firming composition according to any one of claims 1 to 2, characterized in that: The preparation method of the Peucedanum peucedanum extract is as follows: S1, Peucedanum peucedanum was crushed and sieved, then immersed in ethanol for ultrasonic extraction, filtered, the filtrate was collected, the residue was repeatedly extracted 2-3 times, and the obtained filtrate was combined; S2, the filtrate obtained in step S1 is concentrated under reduced pressure, ethanol is recovered until there is no alcohol smell, butanediol is added thereto, stirred evenly, and filtered to obtain the product.
4. The moisturizing, repairing and firming composition according to claim 3, characterized in that: In the step S1, a 30-60 mesh sieve is used for the sieving process; The ethanol is selected from 60% to 85% ethanol, the solid-liquid ratio is 1:8-1:10 (g / mL), and the soaking time is controlled to be 20-40min; the ultrasonic power during the ultrasonic extraction process is 100-300W, and the ultrasonic treatment time is 40-60min; In step S2, the reduced pressure concentration is specifically: performing reduced pressure distillation at 50-60° C. to recover ethanol until there is no alcohol taste to obtain Peucedanum peucedanum concentrated solution, adding 2-2.5 times the mass of butanediol of the Peucedanum peucedanum concentrated solution, stirring evenly, and filtering to obtain the solution.
5. The moisturizing, repairing and firming composition according to claim 1, characterized in that: The preparation method of the quinoa bran extract and artemisia capillaris extract composition is as follows: S1, crude extraction: dry and grind the Artemisia capillaris, sieve it, add water and perform ultrasonic atomization extraction to obtain a crude extract of Artemisia capillaris; Furthermore, the particle size of the dried, crushed and sieved Artemisia capillaris is between 50 mesh and 120 mesh, the mass ratio of the sieved Artemisia capillaris particles to water is 1:6-10, the ultrasonic atomization extraction temperature is controlled at 25-40°C, and the extraction time is 30-35min; S2, deacidification: filtering the crude extract of Artemisia capillaris obtained in step S1, adding neutral alumina thereto, stirring and filtering out solid matter, and obtaining an extract of Artemisia capillaris; Further, the mesh number of the neutral alumina is 80 mesh to 150 mesh, preferably 100 mesh; S3, adsorption: using macroporous resin to adsorb the Artemisia capillaris extract; Further, the macroporous resin is any one or more of D101, AB-8, and HPD-100, preferably AB-8; Furthermore, the macroporous resin is placed in a separation column, and the separation column can be a single column or multiple separation columns connected in series. S4, preparation of eluent: mixing quinoa bran with butanediol, extracting at low temperature by microwave heating, filtering out solid matter, and diluting the filtrate with water to obtain an eluent; Furthermore, the microwave heating extraction temperature is 45-55°C, and the extraction time is 90-100 min; S5, eluting: using the eluate obtained in step S4 to elute the macroporous resin adsorbed with the Artemisia capillaris extract obtained in step S3, to obtain a refined extract; S6, Purification: The refined extract obtained in step S5 is filtered and purified.
6. The moisturizing, repairing and firming composition according to claim 1, characterized in that: The preparation method of the quinoa bran extract and artemisia capillaris extract composition is as follows: S1. Dry and grind quinoa bran and Artemisia capillaris, immerse them in an ethanol solution for ultrasonic-microwave synergistic extraction, centrifuge the extract, take the supernatant and filter it under reduced pressure, collect the filtrate, repeat the extraction of the filter residue 2 to 3 times, and combine the obtained filtrates; S2, the filtrate obtained in step S1 is concentrated under reduced pressure, glycerol is added after concentration, the mixture is stirred evenly, and filtered to obtain the product.
7. The moisturizing, repairing and firming composition according to claim 6, characterized in that: In the step S1, the quinoa bran powder is sieved with a 30-60 mesh sieve, and the Artemisia capillaris powder is sieved with a 40-100 mesh sieve; the feeding ratio of quinoa bran and Artemisia capillaris powder is 1:0.9-1:1.1; The ethanol solution is selected from 50% to 80% ethanol solution, the solid-liquid ratio is 1:45 to 1:60 (g / mL), the ultrasonic power is 100 to 200W, the microwave power is 400 to 500W, the processing temperature is 25°C to 45°C, and the processing time is 1min to 3min during the ultrasonic-microwave synergistic extraction process; In the step S2, the reduced pressure concentration is specifically carried out under reduced pressure distillation at 50-60° C., concentrated to 4-6 times the mass of quinoa bran and Artemisia capillaris powder, and glycerin of the same mass as the concentrated solution is added and stirred evenly.
8. Use of the moisturizing, repairing and firming composition according to any one of claims 1 to 7 in the preparation of cosmetics; Furthermore, the cosmetic has the effect of improving skin dryness, redness, sagging and wrinkles.
9. A cosmetic for improving dryness, redness, sagging and wrinkles of the skin, characterized in that: The cosmetic comprises at least the moisturizing, repairing and firming composition according to any one of claims 1 to 7; Furthermore, the cosmetics may also contain any other raw material ingredients permitted in the cosmetics field, including emulsifiers, emollients, moisturizers, thickeners and preservatives.
10. The method for preparing the cosmetic according to claim 9, characterized in that: The preparation method comprises: a step of mixing the moisturizing, repairing and firming composition according to any one of claims 1 to 7 with other raw material components.
Citation Information
Patent Citations
Skin barrier repairing dressing mask and preparation method thereof
CN112076340A
Compositions and methods for improving bruising and rejuvenating skin
CN114072162A
Preparation method and application of soothing and repairing composition
CN114767595A
Oil-control soothing skin-care composition, cosmetic and preparation method and application of oil-control soothing skin-care composition and cosmetic
CN115252465A
Skin-care composition comprising dill extract
US20100239510A1
